Global Tobacco-Attributable Intracerebral Hemorrhage Burden Declines, Yet Middle-SDI Countries and Males Remain High-Risk
en-GBde-DEes-ESfr-FR

Global Tobacco-Attributable Intracerebral Hemorrhage Burden Declines, Yet Middle-SDI Countries and Males Remain High-Risk

21/11/2026 HEP Journals

Tobacco smoking is a well-established risk factor for intracerebral hemorrhage, yet prior studies have not fully quantified the long-term trends, underlying age-period-cohort effects, or cross-country inequalities in this attributable burden. Understanding these dynamics is critical for targeted prevention.

Using data from the Global Burden of Disease 2021, researchers calculated the estimated annual percentage change (EAPC) in age-standardized rates, applied age-period-cohort (APC) models to decompose temporal effects, and projected trends to 2050 with Bayesian APC (BAPC) models. Global age-standardized mortality and DALY rates fell from 12.04 and 337.56 per 100,000 in 1990 to 6.56 and 179.20 in 2021. Oceania and Southeast Asia had the highest burdens, while middle-SDI countries showed the slowest decline. Males had consistently higher rates than females. APC analysis revealed rising age-related risk, favorable period and cohort effects, and a steeper decline in females. Projections indicate continued decline to 2050, but male rates will remain nearly five times higher than female rates.

This study is the first to integrate APC decomposition, BAPC forecasting, and inequality indices (SII/CIx) to assess tobacco-attributable ICH burden. The findings highlight that despite global progress, middle-SDI countries and males are priority targets. Clinicians and policymakers should intensify smoking cessation, hypertension management, and health education in these populations to sustain the downward trend and reduce health disparities.

The work titled “Trends and sex-specific differences in tobacco-attributable intracerebral hemorrhage burden, 1990–2021: Age-period-cohort analyses and cross-country inequality based on the Global Burden of Disease Study 2021.”, was published on Cardiac Research (accepted on May. 21, 2026).

DOI: 10.1097/re9.0000000000000020
21/11/2026 HEP Journals
Regions: Asia, China
Keywords: Science, Life Sciences

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Témoignages

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Nous travaillons en étroite collaboration avec...


  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2026 by DNN Corp Terms Of Use Privacy Statement